Medical Instruments Disinfections Market Report 2026

The medical instruments disinfections market size has grown strongly in recent years. It will grow from $3.47 billion in 2025 to $3.75 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising healthcare-associated infection cases, increasing hospital infrastructure expansion, growing awareness of infection control protocols, expansion of surgical and diagnostic procedures, stricter regulatory hygiene standards in healthcare settings.

The medical instruments disinfections market size is expected to see strong growth in the next few years. It will grow to $5.2 billion by 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising adoption of automated sterilization systems, increasing demand for sustainable disinfectant chemicals, growth in outpatient and ambulatory surgical procedures, integration of smart tracking in sterilization workflows, expansion of biotechnology-driven infection control solutions. Major trends in the forecast period include low-temperature enzymatic and chemical disinfection process optimization, automated sterilization tracking and validation systems in healthcare facilities, eco-friendly biodegradable medical disinfectant formulation development, advanced surface-compatible antimicrobial coating integration for instruments, rapid high-level disinfection technologies for reusable surgical instruments.

The increasing prevalence of healthcare-associated infections is expected to propel the growth of the medical instrument disinfection market going forward. Healthcare-associated infections refer to infections acquired by patients during the course of receiving treatment within healthcare facilities, which can negatively impact patient safety and clinical outcomes. The rising incidence of healthcare-associated infections is primarily driven by increased hospital utilization, a growing aging population, and a higher prevalence of patients with multiple comorbidities, thereby contributing to sustained market demand. Medical instrument disinfection solutions support healthcare systems by providing effective disinfection technologies that reduce the transmission of infections through contaminated medical instruments and ensure safer patient care environments. For instance, in March 2025, according to the UK Health Security Agency, a UK-based government public health organization, and additionally in January 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, there was an approximate 4% increase in the standardized infection ratio (SIR) for surgical site infections (SSI) across all NHSN operative procedure categories compared to the previous year. Therefore, the increasing prevalence of healthcare-associated infections is propelling the growth of the medical instrument disinfection market, supported by rising infection control requirements and contributing healthcare safety initiatives.

Leading companies operating in the medical instruments disinfection market are focusing on advancing low-temperature sterilization technologies such as vaporized hydrogen peroxide (VHP) systems to enable effective reprocessing of heat-sensitive medical instruments while preserving material integrity and ensuring high-level microbial elimination. Vaporized hydrogen peroxide (VHP) sterilization is a low-temperature method that utilizes reactive hydrogen peroxide vapor to generate free radicals, which effectively destroy microorganisms on delicate medical devices without causing thermal damage. For example, in December 2024, STERIS plc, an Ireland-based provider of products and services that support patient care with an emphasis on infection prevention, received clearance from the U. S. Food and Drug Administration for its V-PRO Low Temperature Sterilizers, designed to sterilize hospital-produced 3D-printed surgical guides and anatomical models. The system is compatible with Formlabs’ BioMed Amber and BioMed Clear resins, ensures dimensional stability, and is validated for use with over 43 materials, supporting safe and efficient disinfection of heat-sensitive instruments.

In November 2023, HOYA Corporation, a Japan-based technology and medical products company, acquired the remaining 49% of shares of WASSENBURG Medical B. V. for an undisclosed amount. Through this acquisition, HOYA aims to strengthen its medical instrument disinfection and flexible endoscopy capabilities by integrating WASSENBURG’s automated endoscope washer-disinfectors, consumables, and related services with its PENTAX Medical division, thereby reinforcing infection control and endoscope reprocessing solutions globally. WASSENBURG Medical B. V. is a Netherlands-based company that provides medical instrument disinfection solutions, specifically for endoscopes through automated washer-disinfectors and reprocessing systems.

Major companies operating in the medical instruments disinfections market are Medline Industries LP, Evonik Industries AG, Ecolab Inc., LANXESS AG, STERIS plc, Getinge AB, PAUL HARTMANN AG, Hu-Friedy Mfg. Co. LLC, Belimed AG, Schülke & Mayr GmbH, 3M Company, Advanced Sterilization Products Inc., Nanosonics Limited, GAMA Healthcare Ltd, Matachana Group S. A., SciCan Ltd., Microgen Bioproducts Ltd, Metrex Research LLC, Tuttnauer Ltd., BODE Chemie GmbH, Wassenburg Medical B. V., Whiteley Corporation Pty Ltd, MMM Group GmbH.

North America was the largest region in the medical instruments disinfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical instruments disinfections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical instruments disinfections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical instruments disinfection market consists of sales of glutaraldehyde solutions, ortho-phthalaldehyde (OPA) disinfectants, peracetic acid formulations, and iodophor disinfectants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.